Oncolytics Biotech
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ONCY and other ETFs, options, and stocks.About ONCY
Oncolytics Biotech, Inc. engages in the provision of development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic, properietary isolation of the reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses.
CEOJared Kelly
CEOJared Kelly
Employees28
Employees28
HeadquartersCalgary, Alberta
HeadquartersCalgary, Alberta
Founded1998
Founded1998
Employees28
Employees28
ONCY Key Statistics
Market cap104.79M
Market cap104.79M
Price-Earnings ratio-3.98
Price-Earnings ratio-3.98
Dividend yield—
Dividend yield—
Average volume607.09K
Average volume607.09K
High today$1.15
High today$1.15
Low today$1.01
Low today$1.01
Open price$1.08
Open price$1.08
Volume611.46K
Volume611.46K
52 Week high$1.53
52 Week high$1.53
52 Week low$0.3258
52 Week low$0.3258
ONCY News
TipRanks 1d
Oncolytics Biotech to Participate in September Investor ConferencesElevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...
Analyst ratings
83%
of 6 ratingsBuy
83.3%
Hold
16.7%
Sell
0%
People also own
Based on the portfolios of people who own ONCY. This list is generated using Robinhood data, and it’s not a recommendation.